The tissue and organ transplantation market involves transplantation procedures that include transplanting tissues or organs from a donor to a recipient. Transplantation is a medical procedure in which an organ or tissue is removed from the body of one person (the organ donor) and placed into the body of another person (the recipient). Tissues and organs that can be transplanted include kidneys, liver, heart, lungs, pancreas, intestine, skin, bone, bone marrow, cornea, heart valves, veins, ligaments and tendons. Organ transplantation has become an established therapeutic option for end-stage organ failure and certain non-malignant diseases for millions of patients worldwide. The increasing number of patients suffering from organ failure and growing organ deficit are fueling the growth of the tissue and organ transplantation market.
The global tissue and organ transplantation market is estimated to be valued at US$ 21.8 billion in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024-2029.
Key Takeaways
Key players operating in the tissue and organ transplantation market are Novartis AG, Teva Pharmaceuticals, Veloxis Pharmaceuticals, Cook Medical, F. Hoffmann-La Roche Ltd., copyright Inc., Zimmer Biomet, Medtronic PLC, Stryker Corporation, Biolife Solutions.
The growing R&D investments and advancements in transplantation techniques along with the rising number of clinical trials present lucrative opportunities in the market. Further, initiatives taken by governments and health organizations to spread awareness about organ donation and transplantation are also fueling the market growth.
The North America region currently dominates the Tissue And Organ Transplantation Market Trends is growing infrastructure & healthcare expenditure, high funding for research and increasing public-private investments to develop innovative therapeutics. However, Asia Pacific region is expected to witness fastest growth during the forecast period owing to increasing organ transplantation procedures and growing healthcare expenditure in the region.
Market Drivers
The rising prevalence of organ failure diseases such as kidney failures, chronic liver disease, cardiovascular diseases, etc.is a key factor behind the increasing demand for Tissue And Organ Transplantation Market Size. According to the statistics, cardiovascular diseases are the leading cause of deaths globally annually. Further, the gap between organ demand and supply has fueled the adoption of transplantation. As per the estimates, over 100,000 patients in the US are in need of organ transplants annually whereas only around 30,000 transplants are performed. This huge unmet medical need drives the growth of the market.
PEST Analysis:
Political: Countries have different donation and transplantation laws which can affect supply and demand. Some countries have opt-out organ donation systems while others require explicit consent.
Economic: Healthcare costs associated with transplantation are quite high. Reimbursement policies and funding mechanisms have a huge impact on affordability and access to transplantation services.
Social: Social beliefs and stigma around organ donation vary greatly by culture and religion. Acceptance levels directly influence potential donor pools and transplant rates.
Technological: Advancements in immunosuppression drugs, organ preservation solutions, tissue engineering and 3D bioprinting are helping address donor organ shortage and expand criteria for recipient eligibility. Developments in living donor transplantations are also increasing.
Geographical Regions:
North America dominates the global tissue and organ transplantation market in terms of value due to factors like high healthcare spending, availability of state-of-art facilities, and presence of major market players. The US accounts for the largest share within the region. Growing geriatric population and rising prevalence of chronic diseases are driving the North American market.
Fastest Growing Region:
Asia Pacific is expected to be the fastest growing regional market driven by increasing healthcare expenditures, growing medical tourism, large patient pools, and rising awareness. Countries like China, India and Japan are at the forefront and witnessing wide acceptance of organ donation and transplantation procedures. The number of transplant centers and trained professionals is also increasing in the region to meet rising demand.
Get more insight on Tissue And Organ Transplantation Market
Unlock More Insights—Explore the Report in the Language You Prefer
Comments on “Tissue and Organ Transplantation Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Organ Failure Cases”